What Were the Top-line Data Results from the LEAP-1 Study?
Steven Gelone, PharmD, shares the topline data yielded from the LEAP-1 study.
Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Recent Videos
Related Content
